Tags

Type your tag names separated by a space and hit enter

Country-to-country transfer of patients and the risk of multi-resistant bacterial infection.
Clin Infect Dis. 2011 Jul 01; 53(1):49-56.CI

Abstract

Management of patients with a history of healthcare contact in multiple countries is now a reality for many clinicians. Leisure tourism, the burgeoning industry of medical tourism, military conflict, natural disasters, and changing patterns of human migration may all contribute to this emerging epidemiological trend. Such individuals may be both vectors and victims of healthcare-associated infection with multiresistant bacteria. Current literature describes intercountry transfer of multiresistant Acinetobacter spp and Klebsiella pneumoniae (including Klebsiella pneumoniae carbapenemase- and New Delhi metallo-β-lactamase-producing strains), methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and hypervirulent Clostridium difficile. Introduction of such organisms to new locations has led to their dissemination within hospitals. Healthcare institutions should have sound infection prevention strategies to mitigate the risk of dissemination of multiresistant organisms from patients who have been admitted to hospitals in other countries. Clinicians may also need to individualize empiric prescribing patterns to reflect the risk of multiresistant organisms in these patients.

Authors+Show Affiliations

University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia. benrogers@uq.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

21653302

Citation

Rogers, Benjamin A., et al. "Country-to-country Transfer of Patients and the Risk of Multi-resistant Bacterial Infection." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 53, no. 1, 2011, pp. 49-56.
Rogers BA, Aminzadeh Z, Hayashi Y, et al. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53(1):49-56.
Rogers, B. A., Aminzadeh, Z., Hayashi, Y., & Paterson, D. L. (2011). Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 53(1), 49-56. https://doi.org/10.1093/cid/cir273
Rogers BA, et al. Country-to-country Transfer of Patients and the Risk of Multi-resistant Bacterial Infection. Clin Infect Dis. 2011 Jul 1;53(1):49-56. PubMed PMID: 21653302.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. AU - Rogers,Benjamin A, AU - Aminzadeh,Zohreh, AU - Hayashi,Yoshiro, AU - Paterson,David L, PY - 2011/6/10/entrez PY - 2011/6/10/pubmed PY - 2011/10/14/medline SP - 49 EP - 56 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin. Infect. Dis. VL - 53 IS - 1 N2 - Management of patients with a history of healthcare contact in multiple countries is now a reality for many clinicians. Leisure tourism, the burgeoning industry of medical tourism, military conflict, natural disasters, and changing patterns of human migration may all contribute to this emerging epidemiological trend. Such individuals may be both vectors and victims of healthcare-associated infection with multiresistant bacteria. Current literature describes intercountry transfer of multiresistant Acinetobacter spp and Klebsiella pneumoniae (including Klebsiella pneumoniae carbapenemase- and New Delhi metallo-β-lactamase-producing strains), methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and hypervirulent Clostridium difficile. Introduction of such organisms to new locations has led to their dissemination within hospitals. Healthcare institutions should have sound infection prevention strategies to mitigate the risk of dissemination of multiresistant organisms from patients who have been admitted to hospitals in other countries. Clinicians may also need to individualize empiric prescribing patterns to reflect the risk of multiresistant organisms in these patients. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/21653302/full_citation L2 - https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cir273 DB - PRIME DP - Unbound Medicine ER -